Key Insights

Highlights

Success Rate

87% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.9%

2 terminated out of 29 trials

Success Rate

86.7%

+0.2% vs benchmark

Late-Stage Pipeline

21%

6 trials in Phase 3/4

Results Transparency

8%

1 of 13 completed with results

Key Signals

1 with results87% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (4)
P 1 (1)
P 2 (1)
P 3 (2)
P 4 (4)

Trial Status

Completed13
Unknown6
Recruiting4
Terminated2
Active Not Recruiting2
Withdrawn1

Trial Success Rate

86.7%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT05927311Completed

Side Effects of Antibiotics in Bone and Joint Infections

NCT06293352Not ApplicableRecruiting

Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection

NCT05753215Phase 2Active Not Recruiting

Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection

NCT03550911Completed

Biological Collection From Samples From The Gut Microbiota In Patients Having A Bone Or Joint Infection Treated By A Suppressive Subcutaneous Antibiotherapy With Betalactamine (CARBAMICROBIOTA)

NCT03704766Not ApplicableRecruitingPrimary

Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis

NCT06132347Withdrawn

Performances of DendrisCHIP®OA in Bone and Joint Infections

NCT05519007Not ApplicableRecruitingPrimary

Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone

NCT05137314Phase 1CompletedPrimary

Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)

NCT04563325Phase 4Completed

Oral-only Antibiotics for Bone and Joint Infections in Children

NCT06827496Recruiting

Initial Oral Antibiotics for Bone and Joint Infections in Children

NCT03713528Phase 4Enrolling By InvitationPrimary

Can Intraosseous Antibiotics Improve the Results of Irrigation & Debridement and Prosthetic Retention for PJI?

NCT06798168UnknownPrimary

Bacteriophage Clinical Trial for Periprosthetic Joint Infection of Multidrug Resistant Pseudomonas Aeruginosa

NCT05341908Completed

Prevalence of Pathogens in Synovial Fluid Obtained From Emergency Department Patients

NCT06402591Phase 3Active Not Recruiting

Results of Extended Versus Single Dose Antibiotic Prophylaxis In Orthopedic Revision Arthroplasty in Nijmegen.

NCT03335592Terminated

Cost of Off-label Antibiotics in Osteoarticular Infections

NCT06267287CompletedPrimary

Microbiological Structure of Pathogens of Periprosthetic Infection of Large Joints in the Post-Covid Period

NCT06191601UnknownPrimary

Interest in Probabilistic Antibiotic Therapy With Broad-spectrum Beta-lactams in Orthopedic Surgery

NCT03426761Phase 4Completed

Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections

NCT05804058CompletedPrimary

Biofilm Composition as a Predictive Biomarker for Prosthetic Joint Infection

NCT04440631Completed

Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection

Scroll to load more

Research Network

Activity Timeline